Infertility Comprehensive Panel Females Test sale cost 540 AED
Estradiol Ultrasensitive Test sale cost 590 AED Estradiol Ultrasensitive Test Cost 650 د.إ Original price was: 650 د.إ.590 د.إCurrent price is: 590 د.إ.
Maternal Serum Screen 2 Dual Test Test sale cost 500 AED Maternal Serum Screen 2 Dual Test Test Cost 560 د.إ Original price was: 560 د.إ.500 د.إCurrent price is: 500 د.إ.
Sale!

Infertility Comprehensive Panel Females Test Cost

Original price was: 600 د.إ.Current price is: 540 د.إ.

-10%

The “Infertility Comprehensive Panel for Females” is a diagnostic test designed to assess various factors that could contribute to infertility in women. Conducted at DNA Labs UAE, this panel encompasses a series of tests aimed at evaluating hormonal balances, ovarian reserve, and other indicators that are crucial in determining a woman’s fertility status. With a cost of 540 AED, the panel is meticulously designed to provide a thorough insight into the potential causes of infertility, facilitating targeted interventions and treatment plans. By analyzing key markers and parameters, this comprehensive test aids healthcare professionals in crafting personalized approaches to support women facing challenges in conceiving, ultimately enhancing their chances of pregnancy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

INFERTILITY COMPREHENSIVE PANEL FEMALES Test

Test cost: AED 540.0

Test Components:

  • FSH
  • LH
  • Prolactin
  • Testosterone, Total
  • TSH Ultrasensitive
  • Estradiol
  • Anti Mullerian Hormone (AMH)

Sample Condition:

4 mL (2 mL min.) serum from 1 SST. Collect specimen 4 hours after the patient has awakened. Overnight fasting is preferred. Ship refrigerated or frozen.

Report Delivery:

Sample Daily by 9 am; Report Same day

Method:

Chemiluminescent Immunoassay, EIA

Test type:

Disorders of Endocrine System, Infertility

Doctor:

Gynecologist, Endocrinologist

Test Department:

Pre Test Information

Overnight fasting is preferred. Collect specimen 4 hours after the patient has awakened. In females, preferred sampling time is Day 2 / Day 3 of the menstrual cycle.

Test Details:

The Infertility Comprehensive Panel for females is a diagnostic test that evaluates various factors that may contribute to infertility in women. This panel typically includes a combination of blood tests, imaging studies, and other diagnostic procedures.

The specific tests included in the panel may vary depending on the healthcare provider and the individual’s specific situation, but commonly included tests are:

  1. Hormone levels: This may include testing for levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, progesterone, and thyroid hormones. These tests can help assess ovarian function and hormone balance.
  2. Ovarian reserve testing: This may include measuring levels of anti-Mullerian hormone (AMH) and/or performing an antral follicle count (AFC) via ultrasound. These tests can provide an estimate of a woman’s remaining egg supply.
  3. Infectious disease screening: This may include tests for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, and HIV. These infections can affect fertility and may require treatment.
  4. Genetic testing: This may include screening for specific genetic disorders that can impact fertility, such as chromosomal abnormalities or mutations in specific genes.
  5. Imaging studies: This may include transvaginal ultrasound to assess the structure of the uterus, fallopian tubes, and ovaries. Hysterosalpingography (HSG) may also be performed to evaluate the patency of the fallopian tubes.
  6. Other tests: Additional tests may be included based on individual circumstances, such as tests for autoimmune disorders, clotting disorders, or other underlying medical conditions that can affect fertility.

The Infertility Comprehensive Panel for females aims to identify any potential causes of infertility and guide appropriate treatment options. It is typically performed after a thorough medical history review and physical examination. The results of these tests can help healthcare providers develop a personalized treatment plan to optimize the chances of achieving pregnancy.

Test Name INFERTILITY COMPREHENSIVE PANEL FEMALES Test
Components *FSH*LH*Prolactin*Testosterone, Total *TSH Ultrasensitive*Estradiol*Anti Mullerian Hormone (AMH)
Price 540.0 AED
Sample Condition 4 mL (2 mL min.) serum from 1 SST. Collectspecimen 4 hours after the patient has awakened. Overnight fasting ispreferred. Ship refrigerated or frozen.
Report Delivery Sample Daily by 9 am; Report Same day
Method Chemiluminescent Immunoassay, EIA
Test type Disorders of Endocrine System, Infertility
Doctor Gynecologist, Endocrinologist
Test Department:
Pre Test Information Overnight fasting ispreferred. Collectspecimen4hoursafterthe patient has awakened. In females, preferred sampling time is Day 2 / Day 3 of the menstrual cycle.
Test Details

The Infertility Comprehensive Panel for females is a diagnostic test that evaluates various factors that may contribute to infertility in women. This panel typically includes a combination of blood tests, imaging studies, and other diagnostic procedures. The specific tests included in the panel may vary depending on the healthcare provider and the individual’s specific situation, but commonly included tests are:

1. Hormone levels: This may include testing for levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, progesterone, and thyroid hormones. These tests can help assess ovarian function and hormone balance.

2. Ovarian reserve testing: This may include measuring levels of anti-Mullerian hormone (AMH) and/or performing an antral follicle count (AFC) via ultrasound. These tests can provide an estimate of a woman’s remaining egg supply.

3. Infectious disease screening: This may include tests for sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, and HIV. These infections can affect fertility and may require treatment.

4. Genetic testing: This may include screening for specific genetic disorders that can impact fertility, such as chromosomal abnormalities or mutations in specific genes.

5. Imaging studies: This may include transvaginal ultrasound to assess the structure of the uterus, fallopian tubes, and ovaries. Hysterosalpingography (HSG) may also be performed to evaluate the patency of the fallopian tubes.

6. Other tests: Additional tests may be included based on individual circumstances, such as tests for autoimmune disorders, clotting disorders, or other underlying medical conditions that can affect fertility.

The Infertility Comprehensive Panel for females aims to identify any potential causes of infertility and guide appropriate treatment options. It is typically performed after a thorough medical history review and physical examination. The results of these tests can help healthcare providers develop a personalized treatment plan to optimize the chances of achieving pregnancy.

SKU: TEST-6230 Category:

Related products